Organisation paid for research Program year 2022 Source: CMS Open Payments

New Phase Research and

Neither a doctor nor a teaching hospital

Research payments

$274,878

24 payments

Through program year 2022, New Phase Research and is reported as receiving $274,878 in research payments, across 24 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$10,500	2
2019	Research	$264,378	22

Breakdown

Who paid Research payments · program years 2019–2022

Ironwood Pharmaceuticals, Inc $264,378 22 payments
Takeda Pharmaceuticals U.S.A., Inc. $10,500 2 payments

Studies the money was for Research payments · program years 2019–2022

McP-103-312 $163,459 10 payments
MD-7246_Mcp103-205 $100,919 12 payments
TAK-951-1501: A Randomized, Double-Blind, Placebo-Controlled Repeated Crossover Study to Evaluate the Safety and Tolerability of Intermittent Single Doses of TAK-951 in the Abortive Treatment of Subjects with Cyclic Vomiting Syndrome. $10,500 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.